Lenacapavir: First Approval (vol 82, pg 1499, 2022)

被引：0

作者：

Paik, Julia ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-023-01908-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1061 / 1061

页数：1

共 50 条

[21] Filgotinib: First Approval (vol 80, pg 1987, 2020)
Dhillon, Sohita
Keam, Susan J.
DRUGS, 2021, 81 (02) : 297 - 297
[22] Contezolid: First Approval (vol 81, pg 1587, 2021)
Hoy, Sheridan M.
DRUGS, 2021, 81 (16) : 1945 - 1945
[23] Vorasidenib: First Approval (vol 84, pg 1325, 2024)
Lamb, Yvette N.
DRUGS, 2024, 84 (12) : 1673 - 1673
[24] Zastaprazan: First Approval (vol 84, pg 863, 2024)
Blair, Hannah A.
DRUGS, 2024, 84 (10) : 1333 - 1333
[25] Concizumab: First Approval (vol 83, pg 1053, 2023)
Keam, Susan J.
DRUGS, 2023, 83 (13) : 1253 - 1254
[26] Oliceridine: First Approval (vol 80, pg 1739, 2020)
Markham, Anthony
DRUGS, 2020, 80 (17) : 1871 - 1871
[27] Lonafarnib: First Approval (vol 81, pg 283, 2020)
Dhillon, Sohita
DRUGS, 2021, 81 (05) : 619 - 619
[28] Zilucoplan: First Approval (vol 84, pg 99, 2023)
Shirley, Matt
DRUGS, 2024, 84 (03) : 373 - 373
[29] Ritlecitinib: First Approval (vol 83, pg 1315, 2023)
Blair, Hannah A.
DRUGS, 2023, 83 (15) : 1457 - 1457
[30] Selpercatinib: First Approval (vol 80, pg 1119, 2020)
Markham, Anthony
DRUGS, 2021, 81 (01) : 181 - 181